Paper41155893
Tannic Acid/Fe(III)-Coated Curcumin Self-Assembled Nanoparticles for Combination Therapy to Treat Triple-Negative Breast Cancer.
Li J and 8 others. Pharmaceutics, 2025. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Tannic Acid/Fe(III)-Coated Curcumin Self-Assembled Nanoparticles for Combination Therapy to Treat Triple-Negative Breast Cancer. Papers, record 41155893. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41155893
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Tannic Acid/Fe(III)-Coated Curcumin Self-Assembled Nanoparticles for Combination Therapy to Treat Triple-Negative Breast Cancer.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 82274111 | National Natural Science Foundation of China | PubMed | ||
| ZYYZDXK-2023272 | Level Construction Disciplines of State Administration of Traditional Chinese Medicine Traditional Chinese Medicine Pharmacy | PubMed |
Source PubMed
References31
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34936300 | Potential of Curcumin and Quercetin in Modulation of Premature Mitochondrial Senescence and Related Changes during Lung Carcinogenesis. | J Environ Pathol Toxicol Oncol | 2021 | https://conductscience.org/library/papers/34936300 | PubMed |
| 2 | 38417295 | Degradable bifunctional phototherapy composites based on upconversion nanoparticle-metal phenolic network for multimodal tumor therapy in the near-infrared biowindow. | J Colloid Interface Sci | 2024 | https://conductscience.org/library/papers/38417295 | PubMed |
| 3 | 33856772 | Facile, Smart, and Degradable Metal-Organic Framework Nanopesticides Gated with FeIII-Tannic Acid Networks in Response to Seven Biological and Environmental Stimuli. | ACS Appl Mater Interfaces | 2021 | https://conductscience.org/library/papers/33856772 | PubMed |
| 4 | 35880107 | Curcumin Alleviates D-Galactose-Induced Cardiomyocyte Senescence by Promoting Autophagy via the SIRT1/AMPK/mTOR Pathway. | Evid Based Complement Alternat Med | 2022 | https://conductscience.org/library/papers/35880107 | PubMed |
| 5 | 36272661 | Metal-phenolic networks with ferroptosis to deliver NIR-responsive CO for synergistic therapy. | J Control Release | 2022 | https://conductscience.org/library/papers/36272661 | PubMed |
| 6 | 36333962 | Engineering metal-phenolic networks for enhancing cancer therapy by tumor microenvironment modulation. | Wiley Interdiscip Rev Nanomed Nanobiotechnol | 2023 | https://conductscience.org/library/papers/36333962 | PubMed |
| 7 | 27683187 | Enhancement of Curcumin Bioavailability Via the Prodrug Approach: Challenges and Prospects. | Eur J Drug Metab Pharmacokinet | 2017 | https://conductscience.org/library/papers/27683187 | PubMed |
| 8 | 35041678 | Curcumin suppresses tumorigenesis by ferroptosis in breast cancer. | PLoS One | 2022 | https://conductscience.org/library/papers/35041678 | PubMed |
| 9 | 34623753 | Metal-Polyphenol-Network Coated Prussian Blue Nanoparticles for Synergistic Ferroptosis and Apoptosis via Triggered GPX4 Inhibition and Concurrent In Situ Bleomycin Toxification. | Small | 2021 | https://conductscience.org/library/papers/34623753 | PubMed |
| 10 | 33656766 | Curcumin induces ferroptosis in non-small-cell lung cancer via activating autophagy. | Thorac Cancer | 2021 | https://conductscience.org/library/papers/33656766 | PubMed |
| 11 | 35695187 | Intrinsically Bioactive Manganese-Eumelanin Nanocomposites Mediated Antioxidation and Anti-Neuroinflammation for Targeted Theranostics of Traumatic Brain Injury. | Adv Healthc Mater | 2022 | https://conductscience.org/library/papers/35695187 | PubMed |
| 12 | 38686676 | Self-Assembled Fe-Phenolic Acid Network Synergizes with Ferroptosis to Enhance Tumor Nanotherapy. | Small | 2024 | https://conductscience.org/library/papers/38686676 | PubMed |
| 13 | 38014635 | Impact of curcumin on ferroptosis-related genes in colorectal cancer: Insights from in-silico and in-vitro studies. | Cell Biochem Funct | 2023 | https://conductscience.org/library/papers/38014635 | PubMed |
| 14 | 40871054 | Palladium Complex-Loaded Magnetite Nanoparticles as Drug Delivery Systems for Targeted Liver Cancer Therapy. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/40871054 | PubMed |
| 15 | 24192454 | Curcumin amorphous solid dispersions: the influence of intra and intermolecular bonding on physical stability. | Pharm Dev Technol | 2014 | https://conductscience.org/library/papers/24192454 | PubMed |
| 16 | 39821470 | Role of long non-coding RNAs and natural products in prostate cancer: insights into key signaling pathways. | Funct Integr Genomics | 2025 | https://conductscience.org/library/papers/39821470 | PubMed |
| 17 | 38527739 | [Guidelines for clinical diagnosis and treatment of advanced triple negative breast cancer in China(2024 edition)]. | Zhonghua Zhong Liu Za Zhi | 2024 | https://conductscience.org/library/papers/38527739 | PubMed |
| 18 | 33294119 | Transcriptome Investigation and In Vitro Verification of Curcumin-Induced HO-1 as a Feature of Ferroptosis in Breast Cancer Cells. | Oxid Med Cell Longev | 2020 | https://conductscience.org/library/papers/33294119 | PubMed |
| 19 | 31896509 | AR ubiquitination induced by the curcumin analog suppresses growth of temozolomide-resistant glioblastoma through disrupting GPX4-Mediated redox homeostasis. | Redox Biol | 2020 | https://conductscience.org/library/papers/31896509 | PubMed |
| 20 | 15325031 | Endothelial cell effects of cytotoxics: balance between desired and unwanted effects. | Cancer Treat Rev | 2004 | https://conductscience.org/library/papers/15325031 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42797301 | Study on Echinacoside-Copper Metal-Phenolic Networks Hydrogel System Loaded with Diallyl Trisulfide for Local Treatment of Cervical Cancer. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42797301 | PubMed |
| 42781638 | TRAIL of Hope: Bioactive Dietary Component-Driven Carrier-Free Nanoplatforms for Synergistically Enhanced Tumor Multimodal Therapy. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42781638 | PubMed |
| 42514903 | Curcumin as a Synergy Amplifier in Cancer Therapy. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42514903 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41155893
GET https://conductscience.org/api/papers/v1/41155893/references?page=2